IMUX — IMMUNIC, INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on IMUX
| date | signal | measured base rate |
|---|---|---|
| 2026-08-11 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-05-28 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-05-15 | Institutional holders jumped in a quarter ownership | -0.52% over 21 days · t = -0.38 · n = 1,553 not distinguishable from its control group |
| 2026-03-10 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-03-05 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-06-13 | Nash Duane Executive Chairman | Open-market purchase | 20.0K | 0.83 | 16.6K |
| 2025-06-05 | Neermann Joerg Director | Open-market purchase | 30.0K | 0.76 | 22.8K |
| 2025-06-05 | Tardio Jason President and COO | Open-market purchase | 12.5K | 0.79 | 9.9K |
| 2025-06-05 | Tardio Jason President and COO | Open-market purchase | 12.5K | 0.79 | 9.9K |
| 2025-06-04 | Neermann Joerg Director | Open-market purchase | 70.0K | 0.77 | 53.9K |
| 2025-06-04 | Vitt Daniel CEO and Director | Open-market purchase | 15.0K | 0.77 | 11.6K |
| 2025-06-04 | Vitt Daniel CEO and Director | Open-market purchase | 15.0K | 0.77 | 11.6K |
| 2025-06-03 | Rudick Richard Alan Director | Open-market purchase | 143.1K | 0.70 | 100.2K |
| 2025-06-03 | Whaley Glenn Chief Financial Officer | Open-market purchase | 45.0K | 0.71 | 31.9K |
| 2025-05-30 | Whaley Glenn Chief Financial Officer | Grant or award | 25.0K | 0.56 | 14.0K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Avidity Partners Management LP | 13.9M | 7.4M |
| Aberdeen Group plc | 9.2M | 8.2M |
| BVF INC/IL | 8.5M | 7.7M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.7M | 5.1M |
| Soleus Capital Management, L.P. | 5.0M | 4.5M |
| Laurion Capital Management LP | 4.3M | 3.9M |
| MILLENNIUM MANAGEMENT LLC | 4.2M | 3.8M |
| MORGAN STANLEY | 3.7M | 3.3M |
| Nantahala Capital Management, LLC | 2.8M | 2.5M |
| 683 Capital Management, LLC | 2.7M | 2.5M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Immunic, Inc. (IMUX) filed form 8-K · 2026-08-11 · SEC EDGAR
- Immunic GAAP EPS of -$0.80 beats by $0.37 · 2026-08-11
- Immunic Appoints Elena Ridloff to Board of Directors · 2026-08-10
Ask the AI about IMUX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →